Last reviewed · How we verify
Placebo caplet of Metformin XR — Competitive Intelligence Brief
phase 3
Diabetes
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo caplet of Metformin XR (Placebo caplet of Metformin XR) — Dexa Medica Group. This is a placebo formulation with no active pharmacological mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo caplet of Metformin XR TARGET | Placebo caplet of Metformin XR | Dexa Medica Group | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo caplet of Metformin XR CI watch — RSS
- Placebo caplet of Metformin XR CI watch — Atom
- Placebo caplet of Metformin XR CI watch — JSON
- Placebo caplet of Metformin XR alone — RSS
Cite this brief
Drug Landscape (2026). Placebo caplet of Metformin XR — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-caplet-of-metformin-xr. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab